Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Biphasic Insulin Aspart Regimens in Type 2 Diabetes
NCT01520753Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 1999
- Primary completion
- Jun 1999
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Fasting serum glucose. Started Mar 1999; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01520753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520753.